Research proposals selected by an international panel of scientists to get answers about CCSVI and MS were announced on June 11. Click here for details on studies being funded by the National MS Society and the MS Society of Canada, including the investigators, goals and study scope.
On June 30, Society VP Dr. Patricia O’Looney will moderate a panel of experts who will cover what’s new in stopping, reversing or preventing MS. Highlights will feature new approaches to disease-modifying therapies, repair and protection research now underway and an international overview of CCSVI research, including insights hoped for from the initial Society CCSVI research grants.
Learn more and sign up now
This communication is partially sponsored through the generous support of Bayer HealthCare and Teva Pharmaceuticals, Inc.